Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nebbioso

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9Martina Pierri, Guglielmo Bove, Erica Gazzillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesotheliomaEnrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heartClaudia Colussi, Jessica Rosati, Stefania Straino, et al.
Ageing Research Reviews|June 1, 2025
"Aging and epigenetic implications in radiotherapy: The promise of BNCT"Chiara Papulino, Marco Crepaldi, Gregorio Favale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in CancerAngela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in CancerAngela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Journal of Cellular Biochemistry|March 4, 2006
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cellsClaudio Scafoglio, Concetta Ambrosino, Luigi Cicatiello, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9Martina Pierri, Guglielmo Bove, Erica Gazzillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesotheliomaEnrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heartClaudia Colussi, Jessica Rosati, Stefania Straino, et al.
Ageing Research Reviews|June 1, 2025
"Aging and epigenetic implications in radiotherapy: The promise of BNCT"Chiara Papulino, Marco Crepaldi, Gregorio Favale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in CancerAngela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Editor's Note: c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in CancerAngela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.
Journal of Cellular Biochemistry|March 4, 2006
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cellsClaudio Scafoglio, Concetta Ambrosino, Luigi Cicatiello, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Pageof 15